For Further Information Contact:
Bioject Medical Technologies Inc.
 

 

 

Ralph Makar
P
resident and CEO
503-692-8001 ext. 4137
  Chris Farrell
Vice President of Finance
503-692-8001 ext. 4132

 

BIOJECT PRESIDENT AND CEO TO PRESENT AT THE ACUMEN BIOFIN
RODMAN & RENSHAW 9TH ANNUAL HEALTHCARE CONFERENCE

PORTLAND, OR, November 5, 2007 Bioject Medical Technologies Inc. (Nasdaq: BJCT), a leading developer of needle-free injection therapy systems, today announced that Mr. Ralph Makar, President and CEO, will present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference, being held November 5-7, 2007.  The presentation will be held Wednesday, November 7, 2007 at 11:30 am (ET) at the New York Palace Hotel in New York City.  

The presentation will be webcast live at http://www.wsw.com/webcast/rrshq12/bjct.  An archived replay will be available at www.bioject.com for 90 days.   

 Bioject Medical Technologies Inc., based in Portland, Oregon, is an innovative developer and manufacturer of needle-free injection therapy systems (NFITS).  NFITS provide an empowering technology and works by forcing medication at high speed through a tiny orifice held against the skin.  This creates a fine stream of high-pressure fluid penetrating the skin and depositing medication in the tissue beneath.  The Company is focused on developing mutually beneficial agreements with leading pharmaceutical, biotechnology, and veterinary companies.

 For more information on Bioject, visit www.bioject.com.